ATAI News and Press, ATAI Life Sciences N.V. From 12/11/22

Summary Welcome to the first ever Psychedelic Sunday episode! There is a lot of overlap between the cannabinoid and psychedelic experiences and today we launch our coverage of the psychedelics industry. Challenges and opportunities within psychedelics. Highlighting 4 stocks: Com...

Interest in psychedelic-assisted therapies has blown up over the past couple of years amid surging interest in psychedelic medications across the mainstream and scientific communities. As America’s mental health crisis has grown, there has been increased interest in alternative treatme...

If you have been paying attention to the internet and the mainstream media for the past couple of years, you probably noticed that psychedelics are all the rage these days. Even though psychedelics are rigidly controlled at the federal level, initial research indicates that they have the potent...

- Dr. Kirpekar joins from Otsuka Pharmaceutical where he was Head of Business Development and Co-chair of the Global Business Development Committee - - He has spent more than 15 years building and growing organizations and businesses in the life sciences and digital health industries - ...

The current wave of surging psychedelic research and mainstream popularity has been dubbed the psychedelic renaissance. Decades after they were prohibited, hallucinogenic drugs are revealing astonishing mental-health benefits in clinical trials. Research has shown that even a single dose...

NEW YORK and BERLIN, Nov. 17, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced it has initiated a clinical study with Massach...

While physicians have worked on developing treatments for physical ailments for centuries, mental health has been neglected for a long time. In recent decades, however, we have become more and more aware of the significant role mental health plays in determining overall health and quality of...

Palm Beach, FL – November 14, 2022 – FinancialNewsMedia.com News Commentary – Anti-anxiety drugs are medications that are used to treat anxiety disorders that are mainly used to relieve anxiety and tension, work by reducing the symptoms of anxiety, such as f...

Atai Life Sciences N.V. (ATAI) Q3 2022 Earnings Conference Call November 10, 2022 08:30 ET Company Participants Stephen Bardin - Chief Financial Officer Florian Brand - Chief Executive Officer and Co-Founder Srini Rao - Chief Scientific Officer and Co-Founder ...

Clinical-stage biopharmaceutical company atai Life Sciences (Nasdaq: ATAI) reported financial results for the third quarter ending Sept. 30, providing updates on its clinical trials looking at the treatment of depression using ketamine – particularly an at-home therapy for ...